PCWorld’s editors selected the best PC hardware and software of 2025/2026, highlighting standout products like the AMD Ryzen 9 9950X3D CPU, Nvidia RTX 5070 Ti graphics card, and Steam Deck handheld ...

June 6 (Reuters) - Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients ‌with type 2 diabetes not using insulin, compared ...

June 6 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not ...

No need to give ChatGPT the run of your system. Instead, use this built-in Windows tool to generate a report that an AI ...

AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...

DexCom reported that CONNECT data showed G7 improved HbA1c and time in range in Type 2 diabetes. DexCom's trial delivered Level A evidence for CGM use in adults with Type 2 diabetes not on insulin.

The FDA gave the green light to Dexcom’s popular over-the-counter glucose monitor Stelo for children 2 years or older who don’t use insulin. (Dexcom) The FDA has given the green light to Dexcom’s ...

Dexcom sponsored CONNECT randomized controlled trial expected to help establish new standard of care for CGM use by people with Type 2 diabetes not using insulin around the world. Showed use of Dexcom ...

Compare Apple Watch CGM apps for blood sugar readings, including Dexcom G7, FreeStyle Libre, and Eversense watch support.

DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of Dexcom G7 leads to clinically and statistically significant reduction in A1C ...

Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...